Condition

HFpEF - Heart Failure With Preserved Ejection Fraction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 29 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials29
Recruiting11
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

29 shown
AlEX-DHF: Ablation and Exercise in Diastolic Heart FailureNCT06650995 · 2027-02-01
RECRUITING
Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection FractionNCT07693049 · 2026-08-10
RECRUITING
Can Tiny Bubbles Offer an Alternative to Catheters for Assessing Pressures Inside the Heart? Investigating Ultrasound Contrast Agents as Pressure Sensors Against Gold Standard Catheter Pressures in Cardiac Catheterisation Patients.NCT07416279 · 2026-02-01
RECRUITING
US Benchmarking Clinical StudyNCT07215715 · 2025-09-16
RECRUITING
MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection FractionNCT06670001 · 2025-06-05
RECRUITING
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan CirculationNCT06762964 · 2025-05-16
RECRUITING
Heart Failure in Patients With Diabetes: Cells, Crosstalk and ConsequencesNCT06774014 · 2025-02-26
RECRUITING
Tailored Exercise Training Study Among Adults With HFpEFNCT07223242 · 2025-02-18
RECRUITING
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable MonitorNCT06699056 · 2024-11-21
RECRUITING
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection FractionNCT05784753 · 2023-11-20
RECRUITING
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)NCT06125925 · 2023-11-06
RECRUITING
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)NCT07855692 · 2026-10-01
NOT_YET_RECRUITING
Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure With Preserved Ejection Fraction (EMPOWER-HFpEF)NCT07727096 · 2026-09-01
NOT_YET_RECRUITING
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart FailureNCT07575672 · 2026-07-01
NOT_YET_RECRUITING
Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)NCT07298993 · 2026-02-02
ENROLLING_BY_INVITATION
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary HypertensionNCT07221513 · 2025-12-15
WITHDRAWN
Testing the CHAT Program for Patients With Heart FailureNCT06994325 · 2025-07-31
COMPLETED
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.NCT07077811 · 2025-06-01
ENROLLING_BY_INVITATION
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection FractionNCT06914141 · 2025-01-14
COMPLETED
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims DataNCT06914102 · 2025-01-14
COMPLETED
Serum IGF1 on Female HFpEF PatientsNCT07015554 · 2025-01-01
ENROLLING_BY_INVITATION
Role of Colchicine as Anti-Inflammatory Therapy in HFpEFNCT06837623 · 2024-07-01
ACTIVE_NOT_RECRUITING
Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary HypertensionNCT06405126 · 2024-02-21
UNKNOWN
Exercise Magnetic Resonance Imaging in Patients With Obesity Associated Heart FailureNCT06514820 · 2024-01-16
UNKNOWN
Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac MonitorNCT05745337 · 2023-02-06
UNKNOWN
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection FractionNCT05637398 · 2022-12-15
COMPLETED
The Gut Microbiota and Metabolites in HFpEFNCT06645535 · 2022-06-30
ENROLLING_BY_INVITATION
Peripheral Microvascular Blood Flow in ANOCANCT05610410 · 2022-01-01
COMPLETED
IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)NCT04826159 · 2021-04-21
COMPLETED

Common interventions

Leading sponsors

Trial status mix

RECRUITING11
COMPLETED6
ENROLLING_BY_INVITATION4
NOT_YET_RECRUITING3
UNKNOWN3
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

NA9
PHASE26
PHASE33
PHASE12
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.